Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis
NCT00050882
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Gastroparesis
Interventions
DRUG:
GM-611
Sponsor
Chugai Pharma USA